El Amri M, Pandit A, Schlosser G
Elife. 2024; 13.
PMID: 39665418
PMC: 11637466.
DOI: 10.7554/eLife.98277.
Lim S, Lee H, Lee H, Kim K, Choi J, Han J
Exp Mol Med. 2024; 56(7):1479-1487.
PMID: 38945955
PMC: 11297275.
DOI: 10.1038/s12276-024-01260-9.
Zhang W, Zhu F, Zhu J, Liu K
Anal Cell Pathol (Amst). 2024; 2024:6681911.
PMID: 38487684
PMC: 10940030.
DOI: 10.1155/2024/6681911.
May-Dracka T, Gao F, Hopkins B, Hronowski X, Chen T, Chodaparambil J
ACS Med Chem Lett. 2022; 13(4):665-673.
PMID: 35450377
PMC: 9014516.
DOI: 10.1021/acsmedchemlett.1c00682.
Bowling F, Frohman M, Airola M
Adv Biol Regul. 2021; 79:100783.
PMID: 33495125
PMC: 8193641.
DOI: 10.1016/j.jbior.2020.100783.
Phospholipase D and Choline Metabolism.
Onono F, Morris A
Handb Exp Pharmacol. 2020; 259:205-218.
PMID: 32086667
PMC: 7768751.
DOI: 10.1007/164_2019_320.
Human PLD structures enable drug design and characterization of isoenzyme selectivity.
Metrick C, Peterson E, Santoro J, Enyedy I, Murugan P, Chen T
Nat Chem Biol. 2020; 16(4):391-399.
PMID: 32042197
DOI: 10.1038/s41589-019-0458-4.
Mammalian phospholipase D: Function, and therapeutics.
McDermott M, Wang Y, Wakelam M, Bankaitis V
Prog Lipid Res. 2019; 78:101018.
PMID: 31830503
PMC: 7233427.
DOI: 10.1016/j.plipres.2019.101018.
Crystal structure of plant PLDα1 reveals catalytic and regulatory mechanisms of eukaryotic phospholipase D.
Li J, Yu F, Guo H, Xiong R, Zhang W, He F
Cell Res. 2019; 30(1):61-69.
PMID: 31619765
PMC: 6951347.
DOI: 10.1038/s41422-019-0244-6.
Preparation and Evaluation of Liposomes Co-Loaded with Doxorubicin, Phospholipase D Inhibitor 5-Fluoro-2-Indolyl Deschlorohalopemide (FIPI) and D-Alpha Tocopheryl Acid Succinate (α-TOS) for Anti-Metastasis.
Song M, Wang J, Lei J, Peng G, Zhang W, Zhang Y
Nanoscale Res Lett. 2019; 14(1):138.
PMID: 31001703
PMC: 6473021.
DOI: 10.1186/s11671-019-2964-4.
mTOR Signalling in Head and Neck Cancer: Heads Up.
Tan F, Bai Y, Saintigny P, Darido C
Cells. 2019; 8(4).
PMID: 30970654
PMC: 6523933.
DOI: 10.3390/cells8040333.
Phosphatidic acid generated by PLD2 promotes the plasma membrane recruitment of IQGAP1 and neointima formation.
Wang Z, Cai M, Tay L, Zhang F, Wu P, Huynh A
FASEB J. 2019; 33(6):6713-6725.
PMID: 30811216
PMC: 6529346.
DOI: 10.1096/fj.201800390RR.
The interface between phosphatidylinositol transfer protein function and phosphoinositide signaling in higher eukaryotes.
Grabon A, Bankaitis V, McDermott M
J Lipid Res. 2018; 60(2):242-268.
PMID: 30504233
PMC: 6358302.
DOI: 10.1194/jlr.R089730.
Proliferative and metastatic roles for Phospholipase D in mouse models of cancer.
Roth E, Frohman M
Adv Biol Regul. 2017; 67:134-140.
PMID: 29154090
PMC: 5910061.
DOI: 10.1016/j.jbior.2017.11.004.
Phospholipase D and Its Essential Role in Cancer.
Cho J, Han J
Mol Cells. 2017; 40(11):805-813.
PMID: 29145720
PMC: 5712509.
DOI: 10.14348/molcells.2017.0241.
Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation.
Noble A, Maitland N, Berney D, Rumsby M
Br J Cancer. 2017; 118(2):189-199.
PMID: 29136407
PMC: 5785744.
DOI: 10.1038/bjc.2017.391.
PLD2 regulates microtubule stability and spindle migration in mouse oocytes during meiotic division.
Liu X, Liu X, Chen D, Jiang X, Ma W
PeerJ. 2017; 5:e3295.
PMID: 28533957
PMC: 5436581.
DOI: 10.7717/peerj.3295.
Targeting phospholipase D in cancer, infection and neurodegenerative disorders.
Brown H, Thomas P, Lindsley C
Nat Rev Drug Discov. 2017; 16(5):351-367.
PMID: 28209987
PMC: 6040825.
DOI: 10.1038/nrd.2016.252.
PLD-Specific Small-Molecule Inhibitors Decrease Tumor-Associated Macrophages and Neutrophils Infiltration in Breast Tumors and Lung and Liver Metastases.
Henkels K, Muppani N, Gomez-Cambronero J
PLoS One. 2016; 11(11):e0166553.
PMID: 27851813
PMC: 5112812.
DOI: 10.1371/journal.pone.0166553.
An Evolutionarily Conserved PLC-PKD-TFEB Pathway for Host Defense.
Najibi M, Labed S, Visvikis O, Irazoqui J
Cell Rep. 2016; 15(8):1728-42.
PMID: 27184844
PMC: 4880541.
DOI: 10.1016/j.celrep.2016.04.052.
